Abstract
Myofibroblastic sarcoma is exceedingly rare, with low-grade features in most cases, and rarely involves the retroperitoneum. The 2020 World Health Organization (WHO) classification of soft tissue tumours still lists only low-grade myofibroblastic sarcoma and shows no consensus on the definitions of high- and intermediate-grade myofibroblastic sarcomas, in contrast to the 2013 WHO classification. Surgical resection of the tumour and adjacent structures is the standard of care for most patients, and intermediate- and high-grade myofibroblastic sarcomas have very poor survival. We describe a patient with intermediate-grade myofibroblastic sarcoma in the retroperitoneum, who underwent en bloc resection and ureteroplasty without adjuvant therapy and was free of pain and any other discomfort during 19 months of follow-up. Key Words: Myofibroblastic sarcoma, Intermediate grade, Retroperitoneum, Surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
